TempP(4)
(Die Seite wurde neu angelegt: „tempp(5) {{tp|p=33206792|t=2020. Promising Nanostructured Materials against Enveloped Virus.|pdf=|usr=022}} {{tp|p=33221521|t=2020. Corticosteroid therapy i…“)
Zum nächsten Versionsunterschied →
Version vom 14. Dezember 2020, 10:44 Uhr
tempp(5)
33206792 2020. Promising Nanostructured Materials against Enveloped Virus.
33221521 2020. Corticosteroid therapy in COVID-19 patients: Don't forget venous thromboembolism.
33274176 2020. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
33283842 2020. The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
33256750 2020. COVID-19 vaccine development: What lessons can we learn from TB?
33284685 2020. Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.
33284679 2020. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
33287311 2020. Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CL(pro), Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach.
33291560 2020. Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications.
33257051 2020. Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.
33224347 2020. Tocilizumab in severe COVID-19.
33281388 2019. Strategies and avenues for COVID-19 - Ayurveda perception.
33276953 2020. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.
33288200 2020. The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2.
33276951 2020. Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation.
33272566 2020. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
33292385 2020. Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology.
33254432 2020. Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques.
33194192 2020. Retrospective analysis of the effect of current clinical medications and clinicopathological factors on viral shedding in COVID-19 patients.
33261847 2020. Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease.
33261845 2020. Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.
33261844 2020. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.
33285430 2020. An insight into the interaction between alpha-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study.
33263104 2020. Convincing the confidence to conquer COVID-19: From epidemiological intervention to laboratory investigation.
33257418 2020. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.
33277291 2020. Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study.
33268426 2020. Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study.
33288208 2020. Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia.
33261670 2020. Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations.
33293741 2020. Ensuring equitable access to COVID-19 vaccines.
33264067 2020. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
33278358 2020. Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
33244174 2020. New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein.
33205469 2020. Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study.
33262454 2020. Structure-based development of human antibody cocktails against SARS-CoV-2.
33262453 2020. Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models.
33262452 2020. Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection.
33262451 2020. SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target.
33278462 2020. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
33262543 2020. COVID-19: Mechanistic model calibration subject to active and varying non-pharmaceutical interventions.
33292336 2020. Anti-COVID-19 drug screening: Frontier concepts and core technologies.
33275095 2020. Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia.
33275094 2020. Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis.
33292313 2020. Vitamin D and Covid-19: an update on evidence and potential therapeutic implications.
33292691 2020. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.
33257340 2020. Difficultes associees a l'evaluation des vaccins contre le SRAS-CoV-2 pendant la pandemie de COVID-19.
33229355 2020. Efficacite et innocuite des corticosteroides dans le traitement de la COVID-19 selon des donnees pour la COVID-19, d'autres infections aux coronavirus, l'influenza, la pneumonie extrahospitaliere et le syndrome de detresse respiratoire aigue : revue systematique et meta-analyse.
33260103 2020. Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2.
33260034 2020. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
33276271 2020. Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein.
33217661 2020. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.
33283069 2020. Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa).
33296558 2020. A Mechanism-based Pharmacokinetic Model of Remdesivir Leveraging Interspecies Scaling to Simulate COVID-19 Treatment in Humans.
33183348 2020. Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study.
33287853 2020. The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study.
33269148 2020. Does Nicotine Prevent Cytokine Storms in COVID-19?
33293238 2020. SARS-CoV-2: Targeted managements and vaccine development.
33275276 2020. Editorial - Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment.
33275275 2020. Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.
33275267 2020. The dual role of anti-viral therapy in the treatment of Coronavirus disease 2019.
33289021 2020. A survey of US hospitals' criteria for the allocation of remdesivir to treat COVID-19.
33293273 2020. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
33267767 2020. Covid-19: Urgent call to action.
33288636 2020. Favipiravir and the Need for Early Ambulatory Treatment of COVID-19.
33293006 2020. Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.
33258925 2020. A pocket guide on how to structure SARS-CoV-2 drugs and therapies.
33292872 2020. The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia.
33264786 2020. Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report.
33257346 2020. Vaccinating the UK against covid-19.
33268462 2020. Covid-19: Moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy.
33268330 2020. Covid-19: UK approves Pfizer and BioNTech vaccine with rollout due to start next week.
33245577 2020. Clinical studies assessing the efficacy, effectiveness, and safety of remdesivir in management of COVID-19: a scoping review.
33226664 2020. Pharmacokinetics under the COVID-19 Storm.
33217038 2020. Chasing COVID-19 chemotherapeutics without putting the cart before the horse.
33269470 2020. Investigating the interaction between nifedipine- and ritonavir-containing antiviral regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis.
33289156 2020. Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future.
33275511 2020. Status of vaccine development for COVID-19.
33275510 2020. A COVID-19 vaccine-dare to dream.
33283265 2020. Low bioavailability hinders drug discovery against COVID-19, guided by in silico docking.
33252988 2021. Low-dose X-ray therapy for COVID-19: lessons from the past.
33285567 2020. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
33279954 2020. A review of COVID-19 biomarkers and drug targets: resources and tools.
33253353 2020. Drug repurposing for COVID-19: could vitamin C combined with glycyrrhizic acid be at play by the findings of Li et al.'s database-based network pharmacology analysis?
33183365 2020. Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
33211371 2020. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
33289334 2020. Repurposing potential of FDA approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
33283984 2020. A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors.
33285564 2020. Paradoxes and uncertainties of immunomodulatory treatments in the fight against COVID-19.
33270137 2020. Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection.
33231098 2020. Experience of conducting clinical trials of investigational medicinal products during a respiratory virus pandemic: Lessons learnt from COVID-19.
33279656 2020. Reporting and design of randomized controlled trials for COVID-19: A systematic review.
33292107 2020. Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters.
33267759 2020. Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.
33272178 2020. Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.
33272180 2020. Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19.
33284199 2020. COVID-19 in older persons: the role of nutrition.
33278121 2020. Emerging cellular and pharmacologic therapies for acute respiratory distress syndrome.
33278108 2020. COVID-19 vaccine development: a pediatric perspective.
33292123 2020. Molecular descriptors of some chemicals that prevent COVID-19.
33261538 2020. Touting Traditional Knowledge and Herbal Medicine to Combat and Prevent COVID-19.
33238863 2020. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
33213322 2020. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
33213320 2020. The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment.
33200697 2020. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.
33267756 2020. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19?
33238848 2020. Mesenchymal stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.
33183205 2020. Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses.
33292135 2020. Docking paradigm: Drug Design.
33292134 2020. An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors.
33262119 2020. Covid-19 vaccination-we need more than the 'mum test'.
33290205 2020. Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces.
33270024 2020. Therapeutic targeting of interleukin-6 for the treatment of COVID-19.
33257213 2020. Stem cell therapy in coronavirus disease 2019: current evidence and future potential.
33251300 2020. Dataset of potential Rhizoma Polygonati compound-druggable targets and partial pharmacokinetics for treatment of COVID-19.
33249199 2020. DPP-4 inhibition and COVID-19: From initial concerns to recent expectations.
33279832 2020. Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.).
33256258 2020. Can Melatonin Be a Potential "Silver Bullet" in Treating COVID-19 Patients?
33239864 2020. Repurposing Anti-Cancer Drugs for COVID-19 Treatment.
33245507 2020. Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.
33259037 2020. Dosing Considerations for Antibodies Against COVID-19.
33232870 2020. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.
33279857 2020. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
33283178 2020. The "sex gap" in COVID-19 trials: a scoping review.
33251500 2020. Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19.
33232205 2020. Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate.
33241728 2020. Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.
33235976 2020. Combating COVID-19 with tissue engineering: a review.
33225219 2020. Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles.
33219496 2020. The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed.
33205620 2020. Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension.
33205539 2020. Hypothetical dysfunction of the epithelial sodium channel may justify neurohumoral blockade in coronavirus disease 2019.
33244631 2020. Reply to the letter to the Editor "Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts".
33241457 2020. Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts.
33239282 2020. Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
33214132 2020. Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy.
33204368 2020. Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): a scoping review.
33200007 2020. The role of physical activity on mental health and quality of life during COVID-19 outbreak: A cross-sectional study.
33225401 2020. Prognostic implications of vitamin D in patients with COVID-19.
33225400 2020. Reply to: Prognostic implications of vitamin D in patients with COVID-19.
33200304 2020. Compassionate use of remdesivir in children with COVID-19.
33249077 2020. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL(pro) and PL(pro)), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2).
33245898 2020. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies.
33227287 2020. A comprehensive review on potential therapeutics interventions for COVID-19.
33227285 2020. A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19.
33275961 2020. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
33271151 2020. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis.
33214204 2020. Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia.
33224256 2020. Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID-19 by Network Pharmacology.
33204291 2020. Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19.
33235797 2020. Old friends meet a new foe: A potential role for immune-priming parasites in mitigating COVID-19 morbidity and mortality.
33262810 2021. Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review).
33199997 2020. Lactoferrin for the treatment of COVID-19 (Review).
33204411 2020. Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19.
33233560 2020. Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review.
33224928 2020. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
33251185 2020. Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking.
33240216 2020. A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic.
33281876 2020. Identification of Potential Key Agents for Targeting RNA-Dependent RNA Polymerase of SARS-CoV-2 by Integrated Analysis and Virtual Drug Screening.
33281589 2020. Update on the Use of Transcranial Electrical Brain Stimulation to Manage Acute and Chronic COVID-19 Symptoms.
33250897 2020. Rapid Response Subunit Vaccine Design in the Absence of Structural Information.
33240278 2020. Adjuvants for Coronavirus Vaccines.
33240265 2020. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.
33262750 2020. Can Algal Derived Bioactive Metabolites Serve as Potential Therapeutics for the Treatment of SARS-CoV-2 Like Viral Infection?
33262747 2020. Current and Future Direct-Acting Antivirals Against COVID-19.
33282914 2020. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives.
33240915 2020. Fasting Ramadan During COVID-19 Pandemic: Immunomodulatory Effect.
33240092 2020. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
33240091 2020. Challenges for Drug Repurposing in the COVID-19 Pandemic Era.
33250777 2020. A Scientific Rationale for Using Cystic Fibrosis Transmembrane Conductance Regulator Therapeutics in COVID-19 Patients.
33224923 2020. Is It Important to Perform Physical Activity During Coronavirus Pandemic (COVID-19)? Driving Action for a Correct Exercise Plan.
33240967 2020. Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro.
33215042 2020. Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach.
33269342 2020. Withania somnifera as a potential future drug molecule for COVID-19.
33225723 2020. The urgent need for pan-antiviral agents: from multitarget discovery to multiscale design.
33215525 2020. The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic.
33206554 2020. Chloroquine/hydroxycloroquine and COVID-19: need to know more about.
33244389 2020. Possible role of zinc (Zn) as an adjunctive therapy in gastrointestinal symptoms of COVID-19 infectious disease.
33294721 2020. Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease.
33292350 2020. An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
33296685 2020. SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.
33294307 2021. Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study.
33280066 2020. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study.
33293837 2020. Targeting Polyamine Metabolism for Control of Human Viral Diseases.
33290969 2020. A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2.
33285283 2020. COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study.
33291769 2020. Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CL(pro) of COVID-19 and Acts as Superoxide Radical Scavenger.
33292521 2020. A ligand-based computational drug repurposing pipeline using KNIME and Programmatic Data Access: case studies for rare diseases and COVID-19.
33292930 2020. Ensuring Safety of Operation Warp Speed Vaccines for COVID-19.
33256484 2020. Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis.
33283567 2020. Repurposing drugs for the management of COVID-19.
33270490 2020. Recent progress in the repurposing of drugs/molecules for the management of COVID-19.
33280467 2020. Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid.
33270594 2020. BIOCHEMICAL ASPECTS OF SYMPTOMATIC TREATMENT IN PATIENTS WITH COVID-19 (REVIEW).
33295829 2020. Exploring the possible use of saponin adjuvants in COVID-19 vaccine.
33270497 2020. COVID-19 in the elderly people and advances in vaccination approaches.
33270484 2020. Plant-based vaccines and antibodies to combat COVID-19: current status and prospects.
33270478 2020. Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward.
33270474 2020. Vaccine safety - is the SARS-CoV-2 vaccine any different?
33281124 2020. Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach.
33283773 2020. Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients.
33257603 2020. Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease.
33283692 2020. IODINE MOUTHWASHES AS DETERRENTS AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2).
33292147 2020. Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study.
33290767 2020. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches.
33191905 2020. A case report of hydroxychloroquine-induced auditory and visual hallucination.
33280207 2020. Hydroxychloroquine/Azithromycin treatment, QT interval and ventricular arrhythmias in hospitalized patients with COVID-19.
33260201 2020. Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.
33247641 2020. Effectiveness of Convalescent Plasma Therapy in the Treatment of Moderate to Severe COVID 19 Patients: A Systematic Review and Meta-Analysis.
33292085 2020. Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches.
33292056 2020. Sensing the interactions between carbohydrate-binding agents and N-linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation studies.
33289456 2020. Virtual screening of phytoconstituents from miracle herb nigella sativa targeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment.
33259429 2020. Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community.
33274473 2020. Science and Evidence-based Review and Approval of COVID-19 Vaccines: A Statement of Support for the U.S. FDA.
33264251 2020. Use of Corticosteroids in COVID-19: Should It Be Considered as a Standard-of-Care Therapy?
33291204 2020. Prognostic Utility of Baseline 25-Hydroxy Vitamin D Levels in Hospitalised COVID-19 Patients: Hope or Hype?
33291202 2020. Vitamin D in COVID-19 Pneumonia: High Yield with Low Risk.
33291194 2020. Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19.
33275483 2020. A Study of Potential SARS-CoV-2 Antiviral Drugs and Preliminary Research of Their Molecular Mechanism, Based on Anti-SARS-CoV Drug Screening and Molecular Dynamics Simulation.
33276017 2020. Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19.
33274479 2020. Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease. A pilot study.
33275101 2020. Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2: a case description.
33289151 2020. Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China.
33270225 2020. Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review.
33289122 2020. Hidden in plain sight: The effects of BCG vaccination in COVID-19 pandemic.
33244378 2020. Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19.
33244375 2020. Nutrition, the digestive system and immunity in COVID-19 infection.
33275129 2020. Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19.
33256385 2020. Complement C5 inhibition in patients with COVID-19 - a promising target?
33256382 2020. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.
33207372 2020. The Role of Glucocorticoids in the Management of COVID-19.
33185497 2020. Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19.
33230502 2020. Successful recovery from coronavirus disease 2019 in a living kidney transplant recipient using low-dose methylprednisolone.
33244901 2020. Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials.
33275896 2020. Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.
33235833 2020. Colchicine in Dermatology: Rediscovering an Old Drug with Novel Uses.
33263242 2020. Repositioning vitamin C as a promising option to alleviate complications associated with COVID-19.
33264668 2020. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
33257619 2020. The shortcomings of tocilizumab in COVID-19.
33196946 2020. COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials.
33263073 2020. DECODING INFORMATION ON COVID - 19: ONTOLOGICAL APPROACH TOWARDS DESIGN POSSIBLE THERAPEUTICS.
33251326 2020. Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019.
33200089 2020. A multiple peptides vaccine against COVID-19 designed from the nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the immunoinformatics approach.
33200088 2020. Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach.
33208294 2020. The effect of thymosin alpha1 on mortality of critical COVID-19 patients: A multicenter retrospective study.
33221168 2020. Potential role of interferons in treating COVID-19 patients.
33278747 2020. Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study.
33214093 2020. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
33259917 2020. Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.
33259916 2020. Hydroxychloroquine lung pharmacokinetics in critically ill patients infected with COVID-19.
33259913 2020. A COVID-19 Prophylaxis? Lower incidence associated with prophylactic administration of Ivermectin.
33213829 2020. Therapeutic modalities and novel approaches in regenerative medicine for COVID-19.
33257908 2020. Vitamin D and COVID-19: Does a Deficiency Point Towards an Unfavorable Outcome?
33212762 2020. Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy?
33248244 2020. Novaferon, Treatment in COVID-19 Patients.
33248243 2020. Reply to "Novaferon, Treatment in COVID-19 Patients".
33278625 2020. A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
33262589 2020. Silver-Based Nanomaterials as Therapeutic Agents Against Coronaviruses: A Review.
33278503 2020. Low-dose Whole-lung Irradiation for COVID-19 Pneumonia: Final Results of a Pilot Study.
33219912 2020. Vitamin D and SARS-CoV-2 infection-evolution of evidence supporting clinical practice and policy development : A position statement from the Covit-D Consortium.
33206336 2020. Remdesivir versus ritonavir/lopinavir in COVID-19 patients.
33283177 2020. Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase.
33205008 2020. Innate and Adaptive Immunity of Murine Neural Stem Cell-Derived piRNA Exosomes/Microvesicles against Pseudotyped SARS-CoV-2 and HIV-Based Lentivirus.
33249784 2020. Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE.
33236590 2020. Hydroxychloroquine-related Rash in COVID-19 Infected Patient.
33236585 2020. Bacillus Calmette-Guerin (BCG) as a Protective Factor for COVID-19?
33236583 2020. Bacillus Calmette-Guerin vaccination Policy and Consumption of Ammonium Chloride-Enriched Confectioneries May Be Factors Reducing COVID-19 Death Rates in Europe.
33220354 2020. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study.
33232684 2020. Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2.
33262017 2020. Understanding COVID - 19 pandemic - A comprehensive Ayurvedic perspective.
33262559 2020. A Critical Analysis of CTRI registered AYUSH studies for COVID- 19.
33250601 2020. Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19.
33210561 2020. Structure-based identification of potential SARS-CoV-2 main protease inhibitors.
33200683 2020. Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.
33200681 2020. Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (m(pro)): a molecular docking, molecular dynamics and structure-activity relationship studies.
33200678 2020. Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19.
33200673 2020. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
33183178 2020. Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches.
33241658 2020. Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
33211389 2020. Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID-19.
33250934 2020. A ligand-based computational drug repurposing pipeline using KNIME and Programmatic Data Access: case studies for rare diseases and COVID-19.
33211672 2020. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers.
33270604 2020. Generating evidence for therapeutic effects: the need for well-conducted randomized trials.
33256141 2020. Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY Trial.
33238464 2020. Drug Repurposing Approaches to Combating Viral Infections.
33213035 2020. Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
33245242 2020. Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019.
33260010 2020. COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study.
33280995 2020. Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS.
33264025 2020. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
33294881 2020. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19.
33263084 2020. Association between high-dose steroid therapy, respiratory function, and time to discharge in patients with COVID-19: Cohort study.
33288313 2020. Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols?
33277107 2020. Passive inhaled mRNA vaccination for SARS-Cov-2.
33257090 2020. COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice?
33295312 2020. SOBERANA, Cuba's COVID-19 Vaccine Candidates: Dagmar Garcia-Rivera PhD.
33294198 2020. Evaluation of electrolyte status of sodium, potassium and magnesium, and fasting blood sugar at the initial admission of individuals with COVID-19 without underlying disease in Golestan Hospital, Kermanshah.
33291720 2020. The Benefits of Vitamin D Supplementation for Athletes: Better Performance and Reduced Risk of COVID-19.
33290972 2020. In silico screening of potential anti-COVID-19 bioactive natural constituents from food sources by molecular docking.
33288411 2020. Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy.
33274249 2020. COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020.
33291642 2020. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
33262924 2021. Probiotics in the prophylaxis of COVID-19: something is better than nothing.
33267577 2020. Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers.
33283100 2020. Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis.
33201345 2020. Use of DPP-4 inhibitors in patients with COVID-19.
33201344 2020. Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19".
33224722 2020. Neutralizing antibodies for the treatment of COVID-19.
33189768 2020. Peptide and peptide-based inhibitors of SARS-CoV-2 entry.
33269093 2020. A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19.
33236114 2020. Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality.
33262663 2020. Antiviral Effects of Oleandrin.
33274246 2020. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis.
33268271 2020. A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful.
33284675 2020. Home-based exercise is associated with improved cardiac functional performance in patients after acute myocardial infarction.
33278866 2020. Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia.
33275385 2020. Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions?
33282414 2020. Is there a place for anti-inflammatory therapy in COVID-19?
33256746 2020. Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice.
33276849 2020. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
33276848 2020. Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
33254589 2020. Role of testosterone in COVID-19 patients - A double-edged sword?
33254584 2020. A hypothesis for examining dihydroxyacetone, the active component in sunless tanning products, as a topical prophylactic against SARS-COV-2 transmission.
33254581 2020. Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?
33254580 2020. Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era.
33254579 2020. Host - virus - drug interactions as determinants of COVID-19's phenotypes: A data-driven hypothesis.
33254564 2020. Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?
33254561 2020. Potential of electric stimulation for the management of COVID-19.
33254555 2020. COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome.
33254551 2020. Can roflumilast become steroid-sparing alternative in the treatment of COVID-19?
33254548 2020. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
33254534 2020. Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities.
33254531 2020. Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?
33254515 2020. Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?
33254514 2020. Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19.
33254510 2020. Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?
33254506 2020. A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression.
33254502 2020. The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients.
33254498 2020. Can charcoal improve outcomes in COVID-19 infections?
33254486 2020. Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: Lesson learned from HIV.
33254484 2020. Methylene blue may have a role in the treatment of COVID-19.
33264276 2020. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
33285740 2020. Inflammatory cytokine depletion in severe coronavirus disease 2019 infectious pneumonia: A case report.
33285727 2020. The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis.
33265927 2020. SARS-CoV-2 Inhibition by Sulfonated Compounds.
33256227 2020. Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro.
33260370 2020. Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study.
33260592 2020. Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein.
33255849 2020. In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2.
33255326 2020. Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach.
33255253 2020. Alkaloids: Therapeutic Potential against Human Coronaviruses.
33287144 2020. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.
33271751 2020. Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach.
33269948 2020. New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment.
33257686 2020. Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.
33261189 2020. Reply to: "Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020, 12, 2757".
33260798 2020. Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: "Vitamin D Deficiency and Outcome of COVID-19 Patients". Nutrients 2020, 12, 2757.
33277150 2020. Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease 2019 (COVID-19) pandemic.
33277149 2020. Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
33257110 2020. Re. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol.
33282067 2020. Electrocardiogrammes d un patient COVID-19 traite par l association hydroxychloroquine et azithromycine.
33282063 2020. 'Any and every cure for COVID-19': an imminent epidemic of alternative remedies amidst the pandemic?
33261173 2020. Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2.
33260813 2020. Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics.
33290397 2020. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.
33264337 2020. A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).
33282201 2020. Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19.
33282314 2021. Improvement of COVID-19 with renal failure and paralytic ileus by using steroids.
33262668 2020. Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.
33281478 2020. The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp.
33257760 2020. Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
33257716 2020. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
33277573 2020. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19.
33262433 2020. High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment.
33262415 2020. A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19.
33262359 2020. Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir.
33262067 2020. The immunology of SARS-CoV-2 infections and vaccines.
33262793 2020. Bruton's Tyrosine Kinase: A Promising Target for the Treatment of COVID-19.
33277207 2020. Convalescent plasma therapy in patients with COVID-19.
33285298 2020. Emergence of Ancient Convalescent plasma (CP) Therapy: to Manage COVID-19 Pandemic.
33281063 2020. Combining Antivirals and Immunomodulators to Fight COVID-19.
33260553 2020. Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis.
33279318 2020. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
33291245 2020. Efforts at COVID-19 Vaccine Development: Challenges and Successes.
33291455 2020. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
33296027 2020. Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19.
33269265 2020. Nafamostat mesylate-induced hyperkalemia in critically ill patients with COVID-19: Four case reports.
33269910 2020. Could Artesunate Have a Positive Effect on the Neurological Complications Related to Infection When It Is Used in the Treatment of COVID-19?
33214807 2020. Targeted Disassembling of SARS-CoV-2 as It Gets Ready for Cell Penetration.
33296498 2020. Effects of Inhaled Nitric Oxide in COVID-19 induced ARDS - is it worthwhile?
33273140 2020. First COVID-19 molecular docking with a chalcone-based compound: synthesis, single-crystal structure and Hirshfeld surface analysis study.
33202150 2020. The Potential of Glycyrrhizinate in the Management of COVID-19: A Systematic Review of the Efficacy and Safety of Glycyrrhizin Preparations in the Treatment of SARS and MERS.
33279332 2020. The role of mesenchymal stem/stromal cells in the acute clinical setting.
33295569 2020. Inteligencia artificial como apoyo a intervenciones no farmacologicas para combatir la COVID-19.
33290446 2020. Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients.
33267713 2020. COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics.
33295720 2020. COVID-19 hastalarinda serum vitamin D duzeyinin klinik seyir ve prognozla iliskisinin degerlendirilmesi.
33277935 2020. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
